The quality issues affected, in the first case, the ability of the quality management system to isolate and identify quality problems within the system. Obviously, within the biology program we also have our quality assurance program, which is headed up by the national technical leader. All issues were eventually identified, but they were not working together as one group to resolve the issues between the quality assurance program as well as the quality management system.
The issue with respect to the results was that we were not able to isolate DNA in some cases where we felt we should have, and that is something we resolved. There were two instances, one in which a manufacturer's kit caused some problems, and the second was a test that was used for the presence of blood, which had additional consequences we had not noted before. It caused a problem with the isolation of DNA from some of those samples.